首页> 外文期刊>Case Reports in Vascular Medicine >An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections
【24h】

An Off-Label Use of a Unibody Aortic Stent-Graft System for the Treatment of Infrarenal Abdominal Aortic Dissections

机译:用于治疗Incraenal腹主动脉夹层的Unibody主动脉支架系统的Off标签使用

获取原文
           

摘要

Infrarenal abdominal aortic dissections (IAAD) are exceedingly rare, accounting for 1-4% of all aortic dissections. The evidence is scarce on how to best manage IAAD when they become symptomatic. Two main interventional approaches exist, open surgery and the endovascular approach. Conventional stent-graft systems make it difficult to treat nonaneurysmal aortic disease due to limb competition in a narrow distal aorta. Thus, we present a novel use of the Endologix Anatomical Fixation 2 (AFX2) Abdominal Aortic Aneurysm (AAA) endograft system for the treatment of four patients with IAAD. We also highlight an individual case study that was treated with an alternative endovascular approach and the complications that followed. This was to highlight and compare our successful experience with Endologix AFX2 AAA endograft system. There were multiple benefits for choosing this stent-graft; however the main advantage is its suitability in the narrow distal aorta. Our aim was to highlight an alternative endovascular approach for the successful treatment of a rare, challenging, and potentially fatal pathology.
机译:Infrarenal腹主动脉夹层(IAAD)非常罕见,占所有主动脉夹层的1-4%。当他们成为症状时,如何最佳管理IAAD的证据是稀缺的。存在两个主要介入方法,开放手术和血管内方法。由于狭窄的远端主动脉中的肢体竞争,常规支架移植系统使得难以治疗非脉瘤主动脉疾病。因此,我们提出了一种新颖的使用Dendologix解剖学固定2(AFX2)腹主动脉动脉瘤(AAA)内血症系统,用于治疗四个患有IAAD患者。我们还突出了一种替代血管内方法治疗的单个案例研究以及随后的并发症。这是突出显示我们使用Endologix AFX2 AAA内传中系统的成功体验。选择这种支架移植物有多种好处;然而,主要优点是其在窄远端主动脉中的适用性。我们的目的是突出一种替代血管内的方法,可以成功地治疗罕见,挑战和潜在的致命病理学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号